Open AccessMore, More, More: Reducing Thrombosis in Acute Coronary Syndromes Beyond Dual Antiplatelet Therapy—Current Data and Future Directions
Author(s) -
Spinthakis Nikolaos,
Farag Mohamed,
Rocca Bianca,
Gorog Diana A.
Publication year - 2018
Publication title -
journal of the american heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.494
H-Index - 85
ISSN - 2047-9980
DOI - 10.1161/jaha.117.007754
Subject(s) - medicine , ticagrelor , clopidogrel , prasugrel , acute coronary syndrome , thrombosis , aspirin , thrombus , cardiology , intensive care medicine , myocardial infarction
Common to the pathogenesis of acute coronary syndromes (ACS) is the formation of arterial thrombus, which results from platelet activation and triggering of the coagulation cascade.[1][1] To attenuate the risk of future thrombotic events, patients with ACS are treated with dual antiplatelet therapy